CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-23 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −1,368 | $130.09 | $178K | 28,882 |
| 2022-02-23 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −609 | $130.23 | $79K | 28,431 |
| 2022-01-03 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +247 | $167.70 | $41K | 11,631.4 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Exercise or conversion | +37,565 | $95.80 | $3.6M | 106,294 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −300 | $153.38 | $46K | 105,994 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −3,250 | $154.79 | $503K | 102,744 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −3,532 | $155.77 | $550K | 99,212 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −15,908 | $156.86 | $2.5M | 83,304 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −14,575 | $157.53 | $2.3M | 68,729 |
| 2021-11-29 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −37,565 | $95.80 | $3.6M | 0 |
| 2021-10-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +288 | $143.77 | $41K | 11,336.62 |
| 2021-08-16 | Doi Tracey Director | Grant or award | +905 | 905 | ||
| 2021-07-29 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +5,300 | $95.80 | $508K | 289,727 |
| 2021-07-29 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −5,300 | $140.59 | $745K | 284,427 |
| 2021-07-29 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +4,193 | $95.80 | $402K | 288,620 |
| 2021-07-29 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −4,193 | $141.22 | $592K | 284,427 |
| 2021-07-29 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −5,300 | $95.80 | $508K | 4,193 |
| 2021-07-29 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −4,193 | $95.80 | $402K | 0 |
| 2021-07-28 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +139,751 | $95.80 | $13.4M | 424,178 |
| 2021-07-28 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −139,751 | $140.14 | $19.6M | 284,427 |
Page 34 of 42 · 826 trades